Frequency News and Research

RSS

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Polycystic ovary syndrome, a common condition among women, can be relieved by the use of acupuncture and exercise. This has been shown by a recent study at the Sahlgrenska Academy, University of Gothenburg, Sweden.

27 Aug 2009

Significant drop in prevalence of rheumatoid vasculitis between 2000 and 2001

Researchers at the University of Wisconsin School of Medicine and Public Health examined records of rheumatoid arthritis (RA) patients from the national Veterans Health Administration (VHA) system to determine the prevalence of rheumatoid vasculitis (RV) in this population. The study found a downward trend in the number of RA patients who go on to develop RV, with a significant drop of 53% among inpatients and 31% among outpatients between 2000 and 2001.

27 Aug 2009

More than half of women with ovarian cancer face delay in diagnosis

Many women with ovarian cancer can go undiagnosed for months because their symptoms are not always being investigated promptly, warn researchers at the University of Bristol in a study published on bmj.com today.

26 Aug 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Saint Vincent Hospital adds RF Surgical Detection System to surgical safety protocols

Saint Vincent Hospital in Worcester, Massachusetts has joined a growing number of over 100 hospitals nationwide to add the RF Surgical Detection System to its surgical safety protocols. This patented and FDA-approved technology uses a scanning wand that detects and signals an alert if any radio frequency tagged surgical sponges remain in a patient following surgery

26 Aug 2009

Sabril (vigabatrin) Oral Solution receives approval from FDA

Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United States approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months.

26 Aug 2009

VeriMed Health Link re-launched by VeriChip Corporation

VeriChip Corporation("VeriChip" or the "Company"), a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, announced today that it is re-launching its VeriMed Health Link electronic health records system.

24 Aug 2009

Research study conducted to analyze long-term patterns in weight-related activities

Despite mounting public health concerns about obesity and persistent social pressures dictating that slim is beautiful, young women in their '20s consistently exercise less than young men.

24 Aug 2009

Link found between teenage viewership and alcohol advertising on cable television

A new study from the Center on Alcohol Marketing and Youth, in collaboration with UCLA, has found a striking correlation between teenage viewership and the frequency of alcohol advertising on cable television. The findings show that ads for beer, spirits and "alcopop" aired much more frequently when more teens were watching.

21 Aug 2009

Eclipsemed collaborates with EndyMed Medical to market the FDA approved radio frequency device

Eclipsemed Ltd, a leading national distributor of advanced medical and aesthetic devices, is pleased to announce that they have collaborated with EndyMed Medical to market the superior EndyMed PRO radio frequency (RF) device to the United States.

20 Aug 2009

New Liquid Water Isotope Analyzer for measuring stable isotopes of liquid water

Los Gatos Research (LGR), the leading innovator of cavity-enhanced laser-based instrumentation for analyses of gases and liquids, today announced the availability of the second-generation Liquid-Water Isotope Analyzer (LWIA).

20 Aug 2009

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment Aptocine(TM) (talaporfin sodium) in Benign Prostatic Hyperplasia (BPH). The Phase 2 trial expands the Aptocine BPH development program on the basis of a Phase 1 study at escalating light doses. In the open-label Phase 2 trial, Aptocine is being tested for safety and efficacy in 40 patients with lower urinary tract symptoms (LUTS) due to BPH. Aptocine is also in two Phase 3 clinical trials for solid tumors in the liver as well as preclinical development for prostate cancer.

19 Aug 2009

Fractal patterns and microchannels to advance tissue engineering

Utilizing fractal patterns similar to those created by lightning strikes, Victor Ugaz, associate professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, has created a network of microchannels that could advance the field of tissue engineering by serving as a three-dimensional vasculature for the support of larger tissue constructs, such as human organs.

18 Aug 2009

1 in 4 children between 11-16 report having sex

As a new mother herself, Brenda Lohman admits to being shocked by the results of a new study she co-authored. It found that among nearly 1,000 low-income families in three major cities, one in four children between the ages of 11 and 16 reported having sex, with their first sexual intercourse experience occurring at the average age of 12.77.

18 Aug 2009

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

CSL Behring announced today that Helixate® FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A who are 16 years old or younger and do not have pre-existing joint damage.

17 Aug 2009

Children, adolescents and headache

Family quarrels and a lack of free time can promote headaches in children. This is what Jennifer Gassmann and her coauthors concluded in their study on risk factors, which appears in the current issue of the Deutsches Ärzteblatt International (Dtsch Arztebl Int 2009; 106[31-32]: 509-16).

17 Aug 2009

Frequency News and Research

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Significant drop in prevalence of rheumatoid vasculitis between 2000 and 2001

More than half of women with ovarian cancer face delay in diagnosis

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Saint Vincent Hospital adds RF Surgical Detection System to surgical safety protocols

Sabril (vigabatrin) Oral Solution receives approval from FDA

VeriMed Health Link re-launched by VeriChip Corporation

Research study conducted to analyze long-term patterns in weight-related activities

Link found between teenage viewership and alcohol advertising on cable television

Eclipsemed collaborates with EndyMed Medical to market the FDA approved radio frequency device

New Liquid Water Isotope Analyzer for measuring stable isotopes of liquid water

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Fractal patterns and microchannels to advance tissue engineering

1 in 4 children between 11-16 report having sex

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

Children, adolescents and headache

FDA approves Extavia for multiple sclerosis

Discovery of inherited gene variants that account for 37 percent of childhood acute lymphoblastic leukemia

Discovery of first gene involved in regulating the optimal length of human sleep

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News